A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.

A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Anti-Idiotypic
Cancer Vaccines
Carcinoembryonic Antigen
Chemotherapy, Adjuvant
Colorectal Neoplasms
Disease-Free Survival
Female
Glycolipids
Glycoproteins
Hepatectomy
Humans
Immunity, Cellular
Immunotherapy
Lipid Droplets
Liver Neoplasms
Male
Middle Aged
Prospective Studies
Survival Rate
Treatment Outcome
Vaccination

authors with profiles

Mitchell Posner
Richard Schilsky
Hedy Kindler